Autres langues Amneal Pharmaceuticals, Inc.

Actions

AMRX

US03168L1052

Marché Fermé - Nasdaq Autres places de cotation 21:59:52 29/05/2024			Varia. 5j.	Varia. 1 janv.
6,78 ^USD	-0,15 %		+1,95 %	+11,70 %

22/05	Amneal commence à fournir le chlorhydrate de naloxone en vaporisateur nasal en vente libre aux pharmacies de détail américaines et à l'État de Californie	CI
06/05	AMNEAL PHARMACEUTICALS, INC. : Goldman Sachs toujours positif	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Amneal Pharmaceuticals Begins Supplying Generic Version of Narcan	22/05
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	22/05
Amneal to Participate at Upcoming Investor Conference	22/05
Amneal Begins Supplying Over-The-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	22/05
Amneal Reports First Quarter 2024 Financial Results	06/05
Drugmaker Amneal agrees to $270 million U.S. opioid settlement	03/05
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	03/05
Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb	03/05
Amneal Pharmaceuticals : First Quarter 2024 Earnings Presentation	03/05
(AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63	03/05
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, vs. Street Est of $619M	03/05
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Posts Q1 EPS $0.14, vs. Street Est of $0.09	03/05
North American Morning Briefing : Apple, Amgen -2-	03/05
Amneal: Q1 Earnings Snapshot	03/05
Amneal Reports First Quarter 2024 Financial Results	03/05
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024	03/05
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug	29/04
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	24/04
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray	24/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Amneal Pharmaceuticals, Inc.

Actions

AMRX

US03168L1052

Autres langues

Filtres